RT Journal Article
SR Electronic
T1 A Deep Learning-based Genome-wide Polygenic Risk Score for Common Diseases Identifies Individuals with Risk
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.17.21265352
DO 10.1101/2021.11.17.21265352
A1 Jiajie Peng
A1 Jingyi Li
A1 Ruijiang Han
A1 Yuxian Wang
A1 Lu Han
A1 Jinghao Peng
A1 Tao Wang
A1 Jianye Hao
A1 Xuequn Shang
A1 Zhongyu Wei
YR 2021
UL http://medrxiv.org/content/early/2021/11/21/2021.11.17.21265352.abstract
AB Identifying individuals at high risk in the population is a key public health need. For many common diseases, individual susceptibility may be influenced by genetic variation. Recently, the clinical potential of polygenic risk score (PRS) has attracted widespread attention. However, the performance of traditional methods is limited in fitting capabilities of the linear model and unable to capture the interaction information between single nucleotide polymorphisms (SNPs). To fill this gap, a novel deep-learning-based model named DeepPRS is developed for scoring the risk of common diseases with genome-wide genotype data. Using the UK Biobank dataset, the evaluation shows that DeepPRS performs better than the other two existing state-of-art methods on Alzheimer’s disease, inflammatory bowel disease, type 2 diabetes and breast cancer. Since DeepPRS does not only rely on the addictive effect of risk SNPs, DeepPRS has the chance to identify high-risk individuals even with few known risk SNPs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by National Natural Science Foundation of China grant No. 62072376 and U1811262.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.